A “lack of time” is the most common reason researchers gave for not publishing their results in an academic journal after presenting them at a conference, according to a new systematic review in the Journal of Clinical Epidemiology. The authors of the review searched for studies that investigated whether abstracts presented at biomedical conferences were […]
In April 2014, following all of your letters, the European Parliament passed the Clinical Trials Regulation with strong transparency measures. Now the European Medicines Agency is seeking feedback on how to implement the new law. You can read the consultation document here.
Read the AllTrials response here and below. Feel free to use our response to help […]
In a reply to questions from the European Ombudsman, the European Medicines Agency (EMA) has published its reasons for agreeing to keep clinical trial information hidden. In 2013, the EMA received requests for documents from clinical trials on the medicine Humira. AbbVie, the manufacturer of Humira, sued the EMA to prevent those documents from being […]